Healthcare -
Biotechnology - NASDAQ - US
$ 45.3
1.14 %
$ 2.62 B
Market Cap
-38.72
P/E
JANX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities JANX - Janux Therapeutics, Inc.
-41.2 M
LAST VALUE
65.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR